Jim Reddoch, PhD’s Post

Assorted snapshots from #ABI25. Thank you to all of our speakers, moderators, and participants for making it a memorable 3 days!

  • No alternative text description for this image
  • No alternative text description for this image
  • No alternative text description for this image
  • No alternative text description for this image
  • No alternative text description for this image
    +15
Matthias Evers

Biopharma exec, advisor & investor | Building at the intersection of human data, discovery & healthspan | Let’s create what’s next

3w

Congrats and thanks, Jim Reddoch, PhD and to the entire Royalty Pharma team and the Massachusetts Institute of Technology of course! Without going here into an in-depth discussion - insights (as well as the networking) were invaluable and if there is one message coming loud and clear - science matters more than ever and we have to ensure we can push forwards on its frontiers! Patients deserve progress.

Andrew Allen

Executive Chairman at Peptone

3w

What a wonderful meeting, Jim, Pablo, Marshall and team - a unique constellation of skills and personalities - congratulations and thank you!

Like
Reply
Arvin Dar

Member and Professor, Chemical Biology, MSKCC. Co-Founder of Nestedtx.com

2w

Amazing - one of the most educational and inspiring conferences that I've ever attended. Congrats Jim, Royalty Pharma, and MIT!

Like
Reply
Michael Secora PhD

Scientist | Investor | Leader

2w

Amazing conference Royalty Pharma and Massachusetts Institute of Technology! Thank you Pablo Legorreta, Jim Reddoch, PhD, and Team for orchestrating such thought-provoking discourse.

Like
Reply
Matt Tremblay, Ph.D.

CEO Blackbird Laboratories

2w

Thanks to Royalty Pharma for hosting another fantastic meeting

Like
Reply
Tom Wyszynski MBA

Financial Advisor at Baystate Financial

3w

Love this, Jim. Congrats on a great event.

Like
Reply
Luke Timmerman

Biotech Journalist, Entrepreneur, Philanthropist

3w

Superb conference. A well-curated mix of scientists, entrepreneurs, investors. One of the best conferences I've attended in 20+ years. Kudos to Jim Reddoch, PhD, the Royalty Pharma team, and MIT.

It was an amazing event as always!

Angela Holmes, MSBME

CEO at OmniScience and Clinical Trials AI Strategist

2w

Thank you for this amazing event! This conference was a masterclass in biomedical innovation and and an exceptional gathering of minds to consider how we can move faster to turn discovery into impact. The message from this conference was clear: those discoveries all start in world-leading academic science labs — and that foundational research must be protected, supported, and translated.

See more comments

To view or add a comment, sign in

Explore topics